Max Robotics — Global Service Robot Directory + US Certification

About

David C. Johnson is a urologic oncologist whose research focuses on optimizing surgical outcomes for patients with bladder and prostate cancers, with a particular emphasis on robotic-assisted techniques and value-based care. His most cited work, a 2017 study on the role of surgical approach in upper tract urothelial carcinoma (64 citations), has helped clarify how lymph node dissection yield and survival outcomes vary by technique—a critical contribution to surgical decision-making. Johnson has also been a pioneer in advancing robot-assisted radical cystectomy, notably authoring a key 2012 paper on robotic intracorporeal urinary diversion for ileal conduits, which demonstrated the feasibility and safety of this minimally invasive approach. His research extends to perioperative management, including a 2020 study on N-methylnaltrexone’s impact on recovery after robotic cystectomy, and health economics, where a 2019 analysis quantified modifiable cost inputs in prostate cancer surgery under episode-based reimbursement models. Through these contributions, Johnson bridges technical innovation with practical outcomes, providing surgeons and health systems with evidence to improve both patient recovery and financial sustainability.